Amyloid Fibrils Composed of Hexameric Peptides Attenuate Neuroinflammation

作者：Kurnellas Michael P; Adams Chris M; Sobel Raymond A; Steinman Lawrence^*; Rothbard Jonathan B

来源：Science Translational Medicine, 2013, 5(179): 179ra42.

DOI：10.1126/scitranslmed.3005681

The amyloid-forming proteins tau, alpha B crystallin, and amyloid P protein are all found in lesions of multiple sclerosis (MS). Our previous work established that amyloidogenic peptides from the small heat shock protein alpha B crystallin (HspB5) and from amyloid beta fibrils, characteristic of Alzheimer's disease, were therapeutic in experimental autoimmune encephalomyelitis (EAE), reflecting aspects of the pathology of MS. To understand the molecular basis for the therapeutic effect, we showed a set of amyloidogenic peptides composed of six amino acids, including those from tau, amyloid beta A4, major prion protein (PrP), HspB5, amylin, serum amyloid P, and insulin B chain, to be anti-inflammatory and capable of reducing serological levels of interleukin-6 and attenuating paralysis in EAE. The chaperone function of the fibrils correlates with the therapeutic outcome. Fibrils composed of tau 623-628 precipitated 49 plasma proteins, including apolipoprotein B-100, clusterin, transthyretin, and complement C3, supporting the hypothesis that the fibrils are active biological agents. Amyloid fibrils thus may provide benefit in MS and other neuroinflammatory disorders.

• 出版日期2013-4-3